Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Guardant Health Inc
(NQ:
GH
)
18.88
+0.30 (+1.61%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Guardant Health Inc
< Previous
1
2
3
4
5
Next >
Guardant Health to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
August 31, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Host Investor Day on September 7, 2023
August 17, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Reports Second Quarter 2023 Financial Results and Increases Revenue Guidance
August 03, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant resolves pending litigation with Illumina and enters into new agreement to advance long-term commercial partnership and cancer research
August 01, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health receives first commercial payor coverage for Guardant Reveal™ test from Blue Cross and Blue Shield of Louisiana
July 20, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Report Second Quarter 2023 Financial Results on August 3, 2023
July 12, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health announces reimbursement approval of Guardant360® CDx liquid biopsy test in Japan
July 05, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to present 17 scientific abstracts highlighting contribution of its blood tests and real-world data to advances in precision oncology and cancer screening at 2023 ASCO annual meeting
May 31, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Participate in Upcoming June Investor Conferences
May 26, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Announces Pricing of Upsized Public Offering of Common Stock
May 22, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Announces Proposed Public Offering of Common Stock
May 22, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Secures Coverage From Major US Commercial Health Insurers for Guardant360® Blood Test for Comprehensive Genomic Profiling
May 17, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Releases Inaugural ESG Report
May 16, 2023
From
Guardant Health, Inc.
Via
Business Wire
A New Groundbreaking Tool to Detect Colon Cancer Earlier
May 10, 2023
A novel blood test for detecting colon cancer, the third most lethal type of cancer in the US, has been created. The Colorectal Cancer Screening Blood Test can identify cancer at early stages. This...
Via
PressReach
Exposures
Product Safety
Guardant Health Reports First Quarter 2023 Financial Results
May 09, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health presents additional information from ECLIPSE study at 2023 Digestive Disease Week on the performance of Shield™ blood test
May 09, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Announces Additions to Leadership Team
May 08, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Announces ECLIPSE Study Update Call on May 9, 2023
May 05, 2023
From
Guardant Health, Inc.
Via
Business Wire
New Artificial Intelligence Tool Can Diagnose Colon Cancer
May 03, 2023
A new artificial intelligence (AI) model developed by Harvard Medical School and Taiwan’s National Cheng Kung University could provide much-needed clarity to clinicians presenting prognoses and...
Via
PressReach
Topics
Artificial Intelligence
Death
Exposures
Artificial Intelligence
Death
Product Safety
Guardant Health to Participate in the BofA Securities 2023 Healthcare Conference
April 27, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health and Parker Institute for Cancer Immunotherapy (PICI) launch research collaboration to study connection between cancer biomarkers and immunotherapy treatment response
April 25, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health announces new data to be presented at 2023 Digestive Disease Week showcasing the potential of its blood-based technology to detect colorectal cancer
April 21, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Report First Quarter 2023 Financial Results on May 9, 2023
April 19, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Receives Medicare Coverage for Guardant360 Response™ to Monitor Cancer Patient Response to Immunotherapy
April 18, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Present Data From 14 Studies Highlighting Advances in Precision Oncology and Cancer Screening at 2023 AACR Annual Meeting
April 11, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health collaborates with The Ohio State University Comprehensive Cancer Center to study colorectal cancer screening adherence
March 21, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health submits premarket approval application to the U.S. Food and Drug Administration for Shield™ blood test
March 10, 2023
From
Guardant Health, Inc.
Via
Business Wire
Musa Tariq Joins Guardant Health Board of Directors
February 27, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Outlook
February 23, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Participate in Upcoming March Investor Conferences
February 17, 2023
From
Guardant Health, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.